Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Takeda Pharmaceutical (TKPHF) FCF Payout Ratio (2018 - 2025)

Historic FCF Payout Ratio for Takeda Pharmaceutical (TKPHF) over the last 8 years, with Q4 2025 value amounting to 0.36.

  • Takeda Pharmaceutical's FCF Payout Ratio fell 590.94% to 0.36 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.25, marking a year-over-year increase of 48.57%. This contributed to the annual value of 0.3 for FY2025, which is 2226.3% down from last year.
  • Takeda Pharmaceutical's FCF Payout Ratio amounted to 0.36 in Q4 2025, which was down 590.94% from 0.02 recorded in Q3 2025.
  • Takeda Pharmaceutical's FCF Payout Ratio's 5-year high stood at 30.14 during Q1 2025, with a 5-year trough of 1.02 in Q2 2022.
  • Its 5-year average for FCF Payout Ratio is 1.64, with a median of 0.18 in 2022.
  • As far as peak fluctuations go, Takeda Pharmaceutical's FCF Payout Ratio plummeted by 12800.07% in 2023, and later surged by 82838.29% in 2025.
  • Takeda Pharmaceutical's FCF Payout Ratio (Quarter) stood at 0.35 in 2021, then grew by 10.72% to 0.31 in 2022, then plummeted by 128.0% to 0.71 in 2023, then soared by 52.52% to 0.34 in 2024, then dropped by 5.91% to 0.36 in 2025.
  • Its FCF Payout Ratio was 0.36 in Q4 2025, compared to 0.02 in Q3 2025 and 0.55 in Q2 2025.